COVID-19: RDIF, Hetero Agree to Produce over 100 Million Doses of Sputnik V Vaccine in India
Moscow /Hyderabad: The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Hetero, one of India’s leading generic pharmaceutical companies have agreed to produce in India over 100 million doses per year of the world’s…